A Phase III Long-Term Study of M610101 in Patients with Atopic Dermatitis
Phase 3
Recruiting
- Conditions
- Atopic dermatitis
- Registration Number
- JPRN-jRCT2031220566
- Lead Sponsor
- Tomoyuki Nishiura
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Patients with atopic dermatitis over 12 years old
Patients with an IGA score of 2 or 3 for atopic dermatitis
Exclusion Criteria
Patients complicated with diseases considered inappropriate for participation in clinical trials such as serious cardiac / hepatic / renal / pulmonary / hematologic disease
Patients with skin diseases other than atopic dermatitis that affect the evaluation of atopic dermatitis or the safety of the subject
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Safety after long-term application of M610101 (up to 52 weeks)<br> (adverse events, laboratory tests, vital signs, ECG)
- Secondary Outcome Measures
Name Time Method